Grammy Award-Winning Everlast to Raise Awareness and Funds for CF Foundation Through Song Download
| 2 min read

To help raise money and awareness for cystic fibrosis, Grammy Award-winning singer/ songwriter/rapper Everlast (a.k.a. Erik Schrody, who has a two-year-old daughter with CF) is supporting the Cystic Fibrosis Foundation through the sale of the song “Long Time.”

Grammy Award-winning singer/songwriter/rapper Erik Schrody has a two-year-old daughter with CF.
Grammy Award-winning singer/songwriter/rapper Erik Schrody has a two-year-old daughter with CF.


From May 8 through May 22, each 99-cent iTunes download of “Long Time” will spur a 65 cent donation (the label's entire proceeds) from Everlast, Martyr Inc. Records and EMI Label Services to the Cystic Fibrosis Foundation.

“Cystic fibrosis is a lifetime battle,” Everlast says. “The CF Foundation is doing a lot of really good work, and they're on the verge of making more big breakthroughs.”

In addition to the “Long Time” donations, Everlast and his family participate in Great Strides, and the artist has recently teamed up with fellow musicians and comedians to further support the search for a cure.

“Long Time” is part of Everlast's album Songs of the Ungrateful Living, a 15-cut collection that highlights the struggles and untapped potential of the nation during the economic recession.

Visit the iTunes store to download Everlast's “Long Time” and support the fight against CF.

Share this article
About the CF Foundation | Fundraising
Recent news
CF Foundation Grateful for Continued Access to Trikafta in Colorado After Prescription Drug Affordability Board’s Ruling
News | 2 min read
CF Foundation Invests Up to $3 Million in ViaNautis Bio to Explore a New Method to Deliver Genetic Therapies to People With CF
News | 2 min read
CF Foundation Formalizes Final Set of Recommendations From External Racial Justice Working Group
News | 4 min read
You might also be interested in...
Stay up to date with The Foundation

Sign up for our newsletter to get all of the latest news from The Foundation right in your inbox.